I. Publications on
Diversity as a Research Priority
Peer Reviewed Article with the ACRP
MBR’s study team is excited to share that the Association of Clinical Research Professionals (ACRP) has published our site’s peer reviewed article on diversity in clinical trials.
The article explores adaptable site level strategies for improving ethnically diverse enrollment in clinical research and offers recommendations to sponsors on how to promote diversity in trial enrollment more broadly.
COVID-19 Treatment Studies
As one of the highest performing Investigators nationally, Dr. Igbinadolor was invited to be a co-author on Eli Lilly’s COVID treatment study publication.
The article discusses Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19.
Novartis’s Scientific Paper on the DARPin therapeutic Ensovibep
As one of the highest performing Investigators nationally, Dr. Igbinadolor was invited to be a co-author on Novartis’s COVID treatment study publication.
The article discusses the results of the placebo controlled phase II study (EMPATHY) investigating the DARPin therapeutic ensovibep, in ambulatory COVID-19 patients.
(Article’s publication is forthcoming in April 2022)